Biological Age And Longevity Diagnostics Market Report 2026

Biological Age And Longevity Diagnostics Market Overview

• Biological Age And Longevity Diagnostics market size has reached to $2.9 billion in 2025 • Expected to grow to $5.58 billion in 2030 at a compound annual growth rate (CAGR) of 13.9% • Growth Driver: Growth In Personalized Medicine Fueling The Growth Of The Market Due To Advances In Genomics And Molecular Diagnostics • Market Trend: AI-Driven Multi-Omics Platform Advances Personalized Aging Assessment And Preventive Health Optimization • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biological Age And Longevity Diagnostics Market?

Biological age and longevity diagnostics refers to advanced medical and analytical approaches used to estimate a person’s biological age based on cellular, genetic, metabolic, and physiological biomarkers rather than chronological age. These diagnostics help assess overall health status, predict disease risk, and guide personalized interventions to improve lifespan and healthspan. The main test types of biological age and longevity diagnostics include epigenetic age testing, telomere length testing, multi omics diagnostics, proteomic aging tests, microbiome based longevity diagnostics, cellular senescence biomarker tests, and organ age assessment tests. Epigenetic age testing refers to diagnostic methods that evaluate biological aging by analyzing DNA methylation patterns and other age-related biomarkers. These tests use sample types including blood samples, saliva samples, urine samples, tissue samples, buccal swab samples, and hair samples. The key applications of preventive healthcare, personalized medicine, chronic disease risk assessment, wellness and fitness monitoring, and anti aging research, while the end-users hospitals and clinics, diagnostic laboratories, research institutes, longevity clinics, academic institutions, direct to consumer users, and pharmaceutical and biotechnology companies.

What Is The Biological Age And Longevity Diagnostics Market Growth Forecast?

The biological age and longevity diagnostics market size is expected to see rapid growth in the next few years. It will grow to $5.58 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to expansion of ai driven precision medicine platforms, rising demand for personalized healthspan extension solutions, increasing integration of multi omics data analytics in diagnostics, growth of direct to consumer longevity testing services, advancement in real time biosensor and wearable diagnostics technologies. Major trends in the forecast period include increasing adoption of multi-omics integration for more accurate biological age prediction and healthspan assessment, rising use of ai-driven longevity models to correlate biomarkers with disease risk and aging trajectories, growing demand for early disease prediction through epigenetic and molecular aging signatures, expansion of personalized anti-aging intervention plans based on biological age diagnostics, increasing use of microbiome and metabolic profiling for holistic aging analysis and health optimization.

Global Biological Age And Longevity Diagnostics Market Segmentation

1) By Test Type: Epigenetic Age Testing; Telomere Length Testing; Multi Omics Diagnostics; Proteomic Aging Tests; Microbiome Based Longevity Diagnostics; Cellular Senescence Biomarker Tests; Organ Age Assessment Tests 2) By Sample Type: Blood Samples; Saliva Samples; Urine Samples; Tissue Samples; Buccal Swab Samples; Hair Samples 3) By Application Type: Preventive Healthcare; Personalized Medicine; Chronic Disease Risk Assessment; Wellness And Fitness Monitoring; Anti Aging Research 4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Longevity Clinics; Academic Institutions; Direct To Consumer Users; Pharmaceutical And Biotechnology Companies Subsegments: 1) By Epigenetic Age Testing: Deoxyribonucleic Acid Methylation Testing; Histone Modification Analysis; Chromatin Accessibility Profiling; Epigenetic Clock Assessment; Age Prediction Biomarker Testing 2) By Telomere Length Testing: Quantitative Polymerase Chain Reaction Testing; Flow Cytometry And Fluorescence In Situ Hybridization; Southern Blot Analysis; Single Telomere Length Analysis; Telomerase Activity Testing 3) By Multi Omics Diagnostics: Genomics Analysis; Transcriptomics Analysis; Proteomics Analysis; Metabolomics Analysis; Lipidomics Analysis 4) By Proteomic Aging Tests: Plasma Protein Biomarker Testing; Inflammatory Protein Analysis; Cytokine Profiling; Enzyme Activity Analysis; Growth Factor Biomarker Testing 5) By Microbiome Based Longevity Diagnostics: Gut Microbiome Sequencing; Microbial Diversity Analysis; Functional Microbiome Profiling; Stool Biomarker Testing; Microbial Metabolite Analysis 6) By Cellular Senescence Biomarker Tests: Senescence Associated Beta Galactosidase Testing; Cellular Stress Marker Analysis; Cell Cycle Arrest Biomarker Testing; Senescence Secretory Phenotype Profiling; Deoxyribonucleic Acid Damage Response Testing 7) By Organ Age Assessment Tests: Cardiovascular Age Assessment; Brain Age Assessment; Liver Age Assessment; Kidney Age Assessment; Lung Age Assessment

What Is The Driver Of The Biological Age And Longevity Diagnostics Market?

The growth in personalized medicine is expected to propel the growth of the biological age and longevity diagnostics market going forward. Personalized medicine refers to a medical approach that uses an individual’s genetic, molecular, and clinical information to customize disease prevention, diagnosis, and treatment strategies for improved patient outcomes. Growth in personalized medicine is primarily driven by advances in genomics and molecular diagnostics, which enable healthcare providers to analyze individual genetic profiles and disease biomarkers to tailor more precise and effective treatments for each patient. Biological age and longevity diagnostics helps personalized medicine by providing individualized insights into an individual’s biological aging processes through molecular, genetic, and biomarker-based assessments, enabling clinicians to tailor prevention, treatment, and lifestyle interventions more precisely than traditional age-based approaches. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the growth in personalized medicine is driving the growth of the biological age and longevity diagnostics industry.

Key Players In The Global Biological Age And Longevity Diagnostics Market

Major companies operating in the biological age and longevity diagnostics market are Altos Labs; Infinite Epigenetics; TruDiagnostic; Viome Life Sciences Inc.; Function Health; Elysium Health Inc.; InsideTracker Inc.; Segterra Inc.; Human Longevity Inc.; FOXO Technologies Inc.; GlycanAge Ltd.; Gero PTE. Ltd.; Decode Age Technologies Pvt. Ltd.; MyDNAge Inc.; Generation Lab; SiPhox Inc; Neko Health; Circulate Health; EpiMedTech Global

Global Biological Age And Longevity Diagnostics Market Trends and Insights

Major companies operating in the biological age and longevity diagnostics market are focusing on developing innovative solutions, such as multi-omics-based longevity assessment platforms, to enable more accurate measurement of biological age and deliver personalized, data-driven preventive healthcare insights. Multi-omics-based longevity assessment platforms integrate genomic, epigenomic, proteomic, metabolomic, and clinical biomarker data to estimate an individual’s biological age, which reflects physiological condition more accurately than chronological age. For instance, in April 2026, Thrive Global, a US-based precision healthcare company, launched the Elite Longevity Assessment, a multi-omics-based longevity assessment platform to evaluate biological age using a combination of advanced biomarker panels, metabolic profiling, and lifestyle data integration. It leverages AI-powered analytics to generate individualized aging scores and healthspan forecasts, helping clinicians identify early signs of accelerated aging and underlying health risks. The assessment further provides personalized intervention recommendations, including nutrition, supplementation, and lifestyle optimization strategies to improve longevity outcomes and preventive care planning. The solution enhances traditional health checkups by shifting focus from disease detection to long-term health optimization and precision aging management.

What Are Latest Mergers And Acquisitions In The Biological Age And Longevity Diagnostics Market?

In April 2026, Infinite Epigenetics, a US-based biotechnology company, acquired Tally Health for an undisclosed amount. With this acquisition, Infinite Epigenetics aims to strengthen its position in the biological age and longevity diagnostics market by combining advanced epigenetic diagnostic capabilities with consumer-focused longevity testing and personalized intervention services to create a vertically integrated healthspan platform. Tally Health LLC is a US-based biotechnology company that provides at-home biological age testing, epigenetic analysis, personalized longevity recommendations, and healthy aging solutions.

Regional Outlook

North America was the largest region in the biological age and longevity diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biological Age And Longevity Diagnostics Market?

The biological age and longevity diagnostics market consists of revenues earned by entities by providing services such as blood biomarker analysis, multi-omics profiling, and longevity health consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The biological age and longevity diagnostics market also includes sales of biological age testing kits, epigenetic and genetic testing products, biomarker analysis panels, wearable health monitoring devices, and biosensors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biological Age And Longevity Diagnostics Market Report 2026?

The biological age and longevity diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biological age and longevity diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.